 Aurelie Ledreux
Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain-Derived Neurotrophic Factor | 5 | 2019 | 110 | 1.470 |
Why?
| | Down Syndrome | 8 | 2021 | 477 | 1.140 |
Why?
| | Alzheimer Disease | 7 | 2021 | 514 | 1.090 |
Why?
| | Hippocampus | 5 | 2020 | 871 | 1.060 |
Why?
| | Exosomes | 4 | 2019 | 96 | 0.970 |
Why?
| | Marine Toxins | 5 | 2012 | 12 | 0.930 |
Why?
| | Healthy Aging | 2 | 2019 | 34 | 0.730 |
Why?
| | Norepinephrine | 2 | 2017 | 210 | 0.650 |
Why?
| | Mindfulness | 2 | 2019 | 116 | 0.650 |
Why?
| | tau Proteins | 5 | 2020 | 76 | 0.630 |
Why?
| | Ciguatoxins | 2 | 2020 | 2 | 0.590 |
Why?
| | Aging | 2 | 2017 | 1774 | 0.530 |
Why?
| | Memory, Short-Term | 2 | 2017 | 263 | 0.530 |
Why?
| | Spatial Memory | 1 | 2016 | 24 | 0.520 |
Why?
| | Indans | 1 | 2015 | 11 | 0.500 |
Why?
| | Shellfish | 2 | 2012 | 6 | 0.490 |
Why?
| | Diet, High-Fat | 1 | 2016 | 239 | 0.460 |
Why?
| | Parkinson Disease | 2 | 2022 | 461 | 0.460 |
Why?
| | Learning | 1 | 2019 | 401 | 0.460 |
Why?
| | Encephalitis | 1 | 2016 | 132 | 0.450 |
Why?
| | Cholesterol | 1 | 2016 | 412 | 0.450 |
Why?
| | Cognition | 3 | 2019 | 1122 | 0.450 |
Why?
| | Neuroblastoma | 3 | 2013 | 151 | 0.440 |
Why?
| | Ciguatera Poisoning | 1 | 2013 | 2 | 0.420 |
Why?
| | Neurons | 2 | 2019 | 1494 | 0.400 |
Why?
| | Cooperative Behavior | 2 | 2012 | 433 | 0.390 |
Why?
| | Brain Concussion | 1 | 2019 | 549 | 0.360 |
Why?
| | Amyloid beta-Peptides | 4 | 2021 | 211 | 0.350 |
Why?
| | Exercise | 2 | 2019 | 1925 | 0.340 |
Why?
| | Memory Disorders | 2 | 2020 | 168 | 0.300 |
Why?
| | Acrylamides | 1 | 2008 | 57 | 0.300 |
Why?
| | Rats, Inbred F344 | 3 | 2017 | 259 | 0.290 |
Why?
| | Benzylamines | 2 | 2017 | 41 | 0.270 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2023 | 833 | 0.270 |
Why?
| | Inflammation | 1 | 2017 | 2737 | 0.270 |
Why?
| | Biomarkers | 5 | 2023 | 3968 | 0.260 |
Why?
| | Locomotion | 2 | 2017 | 100 | 0.250 |
Why?
| | Brain | 4 | 2020 | 2669 | 0.250 |
Why?
| | Microglia | 2 | 2017 | 232 | 0.230 |
Why?
| | Chromatography, Liquid | 2 | 2020 | 424 | 0.230 |
Why?
| | Cyanobacteria | 3 | 2014 | 50 | 0.230 |
Why?
| | Tandem Mass Spectrometry | 3 | 2020 | 523 | 0.220 |
Why?
| | Rats | 4 | 2020 | 5482 | 0.220 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2023 | 26 | 0.210 |
Why?
| | Animals | 15 | 2020 | 35309 | 0.210 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2023 | 73 | 0.200 |
Why?
| | alpha-Synuclein | 1 | 2022 | 31 | 0.190 |
Why?
| | Amyloidogenic Proteins | 1 | 2020 | 16 | 0.180 |
Why?
| | Male | 13 | 2020 | 63512 | 0.170 |
Why?
| | Adrenergic Neurons | 1 | 2019 | 4 | 0.170 |
Why?
| | Eicosapentaenoic Acid | 1 | 2020 | 36 | 0.160 |
Why?
| | Locus Coeruleus | 1 | 2019 | 21 | 0.160 |
Why?
| | Staining and Labeling | 1 | 2019 | 141 | 0.160 |
Why?
| | Protein Precursors | 1 | 2019 | 128 | 0.160 |
Why?
| | Healthy Lifestyle | 1 | 2019 | 32 | 0.150 |
Why?
| | Endocytosis | 1 | 2019 | 163 | 0.150 |
Why?
| | Multiple Sclerosis | 1 | 2023 | 436 | 0.140 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2017 | 71 | 0.140 |
Why?
| | Nerve Degeneration | 1 | 2017 | 47 | 0.140 |
Why?
| | Analysis of Variance | 2 | 2017 | 1288 | 0.140 |
Why?
| | Cell Survival | 2 | 2013 | 1075 | 0.140 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2017 | 91 | 0.140 |
Why?
| | Extracellular Vesicles | 1 | 2019 | 129 | 0.140 |
Why?
| | Microfilament Proteins | 1 | 2017 | 128 | 0.140 |
Why?
| | Fluorescent Antibody Technique | 1 | 2017 | 376 | 0.140 |
Why?
| | Chemokines | 1 | 2017 | 226 | 0.130 |
Why?
| | Task Performance and Analysis | 1 | 2017 | 173 | 0.130 |
Why?
| | Calbindin 1 | 1 | 2016 | 1 | 0.130 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 211 | 0.130 |
Why?
| | Bacterial Toxins | 2 | 2008 | 104 | 0.130 |
Why?
| | Microcystins | 2 | 2014 | 7 | 0.130 |
Why?
| | Monoamine Oxidase Inhibitors | 1 | 2015 | 15 | 0.130 |
Why?
| | Pyramidal Cells | 1 | 2016 | 69 | 0.130 |
Why?
| | Midazolam | 1 | 2016 | 53 | 0.130 |
Why?
| | Chaperonin 60 | 1 | 2015 | 14 | 0.130 |
Why?
| | Astrocytes | 1 | 2017 | 196 | 0.130 |
Why?
| | Monoamine Oxidase | 1 | 2015 | 27 | 0.120 |
Why?
| | Cell Line, Tumor | 4 | 2013 | 3202 | 0.120 |
Why?
| | Phosphorylation | 2 | 2019 | 1710 | 0.120 |
Why?
| | Anesthetics | 1 | 2016 | 66 | 0.120 |
Why?
| | Interleukin-1beta | 1 | 2017 | 372 | 0.120 |
Why?
| | Diet, Western | 1 | 2016 | 79 | 0.120 |
Why?
| | Inhibitory Concentration 50 | 2 | 2012 | 86 | 0.120 |
Why?
| | Microtubule-Associated Proteins | 1 | 2016 | 192 | 0.120 |
Why?
| | Neuroprotective Agents | 1 | 2015 | 122 | 0.110 |
Why?
| | Colorimetry | 1 | 2014 | 11 | 0.110 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 877 | 0.110 |
Why?
| | Neuropsychological Tests | 1 | 2019 | 1014 | 0.110 |
Why?
| | Single-Chain Antibodies | 1 | 2014 | 17 | 0.110 |
Why?
| | Memory | 1 | 2016 | 255 | 0.110 |
Why?
| | Water Microbiology | 1 | 2014 | 82 | 0.110 |
Why?
| | Neuroimaging | 1 | 2016 | 278 | 0.110 |
Why?
| | Alkaline Phosphatase | 1 | 2014 | 146 | 0.110 |
Why?
| | Humans | 15 | 2023 | 129266 | 0.100 |
Why?
| | Injections, Intraperitoneal | 1 | 2013 | 111 | 0.100 |
Why?
| | Dopamine | 1 | 2015 | 287 | 0.100 |
Why?
| | Half-Life | 1 | 2013 | 162 | 0.100 |
Why?
| | Chronic Disease | 1 | 2019 | 1716 | 0.100 |
Why?
| | Sodium Channels | 1 | 2013 | 65 | 0.100 |
Why?
| | Biological Availability | 1 | 2013 | 147 | 0.100 |
Why?
| | Injections, Intravenous | 1 | 2013 | 202 | 0.100 |
Why?
| | Escherichia coli Proteins | 1 | 2014 | 178 | 0.100 |
Why?
| | Area Under Curve | 1 | 2013 | 304 | 0.100 |
Why?
| | Behavior, Animal | 1 | 2015 | 506 | 0.100 |
Why?
| | Disease Models, Animal | 3 | 2019 | 4057 | 0.100 |
Why?
| | Cognition Disorders | 1 | 2016 | 505 | 0.090 |
Why?
| | Tropanes | 2 | 2008 | 5 | 0.090 |
Why?
| | Recombinant Proteins | 1 | 2014 | 1304 | 0.090 |
Why?
| | Administration, Oral | 1 | 2013 | 785 | 0.090 |
Why?
| | Cell Line | 2 | 2012 | 2779 | 0.080 |
Why?
| | Mice | 5 | 2019 | 16915 | 0.080 |
Why?
| | Cnidarian Venoms | 1 | 2008 | 1 | 0.080 |
Why?
| | Bivalvia | 1 | 2008 | 7 | 0.080 |
Why?
| | Torpedo | 1 | 2008 | 10 | 0.080 |
Why?
| | Biological Assay | 1 | 2008 | 118 | 0.070 |
Why?
| | Maze Learning | 2 | 2020 | 104 | 0.070 |
Why?
| | Aged | 4 | 2020 | 22032 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5050 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2396 | 0.070 |
Why?
| | Female | 6 | 2020 | 68551 | 0.070 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2008 | 215 | 0.060 |
Why?
| | Neurotoxins | 1 | 2005 | 28 | 0.060 |
Why?
| | Young Adult | 2 | 2019 | 12391 | 0.060 |
Why?
| | Mice, Transgenic | 2 | 2020 | 2117 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2012 | 3080 | 0.060 |
Why?
| | Poisoning | 1 | 2005 | 111 | 0.060 |
Why?
| | Amyloid | 1 | 2022 | 85 | 0.050 |
Why?
| | Autopsy | 1 | 2020 | 92 | 0.040 |
Why?
| | Seals, Earless | 1 | 2020 | 3 | 0.040 |
Why?
| | Acetonitriles | 1 | 2020 | 11 | 0.040 |
Why?
| | Limit of Detection | 1 | 2020 | 82 | 0.040 |
Why?
| | Designer Drugs | 1 | 2019 | 8 | 0.040 |
Why?
| | Adult | 2 | 2020 | 35495 | 0.040 |
Why?
| | Receptor, trkB | 1 | 2019 | 30 | 0.040 |
Why?
| | Solvents | 1 | 2020 | 108 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2023 | 848 | 0.040 |
Why?
| | Cell Communication | 1 | 2019 | 300 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2020 | 7055 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 2019 | 476 | 0.030 |
Why?
| | Voltage-Dependent Anion Channel 2 | 1 | 2016 | 1 | 0.030 |
Why?
| | Voltage-Dependent Anion Channel 1 | 1 | 2016 | 9 | 0.030 |
Why?
| | Neuropathology | 1 | 2016 | 4 | 0.030 |
Why?
| | Cognitive Dysfunction | 1 | 2020 | 346 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2016 | 97 | 0.030 |
Why?
| | Intra-Abdominal Fat | 1 | 2016 | 88 | 0.030 |
Why?
| | Organ Size | 1 | 2016 | 446 | 0.030 |
Why?
| | Teaching | 1 | 2017 | 214 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2017 | 521 | 0.030 |
Why?
| | Coloring Agents | 1 | 2014 | 77 | 0.030 |
Why?
| | Middle Aged | 3 | 2020 | 31090 | 0.030 |
Why?
| | Liver | 2 | 2016 | 1839 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2016 | 692 | 0.020 |
Why?
| | Epitopes | 1 | 2014 | 470 | 0.020 |
Why?
| | Body Weight | 1 | 2016 | 939 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 3140 | 0.020 |
Why?
| | Bungarotoxins | 1 | 2008 | 45 | 0.020 |
Why?
| | Color | 1 | 2008 | 73 | 0.020 |
Why?
| | Luminescent Measurements | 1 | 2008 | 75 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2011 | 0.020 |
Why?
| | Apoptosis | 1 | 2016 | 2499 | 0.020 |
Why?
| | Calibration | 1 | 2007 | 140 | 0.020 |
Why?
| | Reference Standards | 1 | 2007 | 176 | 0.020 |
Why?
| | Laboratories | 1 | 2007 | 108 | 0.020 |
Why?
| | Receptors, Nicotinic | 1 | 2008 | 329 | 0.020 |
Why?
| | Saxitoxin | 1 | 2005 | 3 | 0.020 |
Why?
| | Gastrointestinal Contents | 1 | 2005 | 7 | 0.020 |
Why?
| | France | 1 | 2005 | 29 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2007 | 580 | 0.010 |
Why?
| | Rivers | 1 | 2005 | 58 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2008 | 713 | 0.010 |
Why?
| | Dogs | 1 | 2005 | 382 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 2005 | 256 | 0.010 |
Why?
| | Environmental Monitoring | 1 | 2005 | 306 | 0.010 |
Why?
| | Intestines | 1 | 2005 | 347 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 20313 | 0.010 |
Why?
|
|
Ledreux's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|